Industry News
Pharmaceutical Industry News
After three decades of no new…
After three decades of no new antibiotics for the treatment of gonorrhea, the FDA has signed off on two first-in-class oral treatments for the sexually transmitted infection. The U.S. regulator has green lit Innoviva’s Nuzolvence
The CDC findings were released as…
The CDC findings were released as the FDA considers placing a black box safety warning on COVID vaccines, according to a CNN report.
GSK’s depemokimab, a long-acting…
GSK’s depemokimab, a long-acting biologic that’s key to the British pharma’s growth plan, has won an endorsement from European regulators for approval in asthma and chronic rhinosinusitis with nasal polyps.
As it shifts strategic direction…
As it shifts strategic direction to prioritize its recently acquired ENvue feeding tube placement system, NanoVibronix is changing its name to reflect the new focus.
Thursday, the FDA greenlighted…
Thursday, the FDA greenlighted Uplizna to treat generalized myasthenia gravis in adults who are anti-acetylcholine receptor and anti-muscle specific tyrosine kinase antibody positive. After two loading doses, Uplizna for gMG is administered just twice a
With an increase in the…
With an increase in the antimicrobial resistance to therapies for gonorrhea, doctors have been left with fewer options to treat the sexually transmitted infection. Thursday, the FDA addressed the shortfall with a label expansion for
Pfizer is paying top dollar for a…
Pfizer is paying top dollar for a GLP-1 candidate from Fosun. Zealand Pharma penned a platform deal with a brand new Chinese biotech to work on drugs for metabolic diseases. China unveiled its first Commercial
The long-planned legislation…
The long-planned legislation contains "encouraging steps" but is overall "not strong enough to move the needle" on European competitiveness, the European Federation of Pharmaceutical Industries and Associations said in a statement.
After winning an approval decades…
After winning an approval decades in the making last year—and shuffling its executive roster throughout 2025—Geron Corporation is scaling back its head count.
Abbott has put the ball back in…
Abbott has put the ball back in Serena Williams’ court to serve up a high-profile endorsement of the Lingo over-the-counter glucose sensor.
After three decades spent rising…
After three decades spent rising through the ranks of sales and marketing teams at major pharmas, Chris Boulton is taking the top spot at an obesity-focused biotech.
How Long Should You Take Antidepressants?
Clinical guidelines are vague, so we asked psychiatrists what to consider when deciding whether to continue taking these medications.
Eli Lilly will not seek a broad…
Eli Lilly will not seek a broad FDA approval for a combination of the company’s oral SERD med Inluriyo and CDK4/6 inhibitor Verzenio despite seemingly promising phase 3 results.
As part of a multi-year…
As part of a multi-year cost-cutting initiative, Pfizer is “making changes in Switzerland to ensure we have the best strategies and models in place to deliver our medicines and vaccines to patients,” a company spokesperson
About a year and a half after…
About a year and a half after telegraphing plans to shift its headquarters from New Jersey to Philadelphia, CDMO Adare Pharma Solutions appears to be turning out the lights at another facility in the City
After pressure from the FTC, Teva…
After pressure from the FTC, Teva has asked the FDA to delist hundreds of patents on products for asthma, diabetes, chronic obstructive pulmonary disease and for epinephrine autoinjectors, the agency said.
A year after a clutch of major…
A year after a clutch of major pharmas threw their weight behind a new campaign devoted to addressing the serious health disparities facing Black breast cancer patients, “Care for HER” has been shown to have
A new guidance document issued by…
A new guidance document issued by the FDA this week offers recommendations for how makers of prescription biosimilars and biologic reference products should approach promotional advertising and labeling for those meds.
The U.K. is upholding its end of a…
The U.K. is upholding its end of a recent trade deal with the U.S., increasing the island country’s potential spending on new medicines by cutting the rebates paid by pharma companies under a cost-control scheme.
Italian nonprofit Fondazione…
Italian nonprofit Fondazione Telethon's Waskyra is an ex vivo gene therapy that can address the root genetic cause of Wiskott-Aldrich syndrome in children and adults.